Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
valeria.riccieri@uniroma1.it
Valeria Riccieri
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
valeria.riccieri@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
CT evaluation of interstitial lung disease related to systemic sclerosis: visual versus automated assessment. A systematic review
CLINICAL RADIOLOGY
2024
Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort
REUMATISMO
2024
Plasma CXCL4–DNA/RNA Complexes and Anti-CXCL4 Antibodies Modulation in an SSc Cohort under Iloprost Treatment
REPORTS
2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosis
RHEUMATOLOGY
2024
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors.
REUMATISMO
2024
Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study
RHEUMATOLOGY
2023
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2023
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology
RMD OPEN
2023
Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis
RHEUMATOLOGY
2023
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase
JOURNAL OF TRANSLATIONAL AUTOIMMUNITY
2023
Safety of multiple vaccinations and durability of vaccine‐induced antibodies in an Italian military cohort 5 years after immunization
BIOMEDICINES
2022
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022
Lack of cross-reactivity between rheumatoid factor IgM and anti-S1 receptor binding domain of SARS-CoV-2 IgM: a case-control study
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature
AUTOIMMUNITY REVIEWS
2022
Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
PLOS ONE
2022
The prostacyclin analogue Iloprost modulates CXCL10 in systemic sclerosis
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2022
An italian multicenter study on anti-NXP2 antibodies. clinical and serological associations
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
2022
Peripheral microangiopathy changes in pulmonary arterial hypertension related to systemic sclerosis- data from a multicenter observational study
FRONTIERS IN CARDIOVASCULAR MEDICINE
2022
Psychological fragility in an italian cohort of systemic sclerosis patients during covid-19 pandemic category. short communication
OPEN ACCESS RHEUMATOLOGY
2022
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022
1
2
3
4
5
seguente ›
ultima »
Progetti di Ricerca
Da VEDOSS (Very Early Diagnosis of Systemic Sclerosis) a Sclerosi Sistemica secondo i nuovi Criteri Classificativi ACR/EULAR del 2013: ruolo predittivo di indicatori precoci, strumentali e di laboratorio
Neoplasie e Sclerosi Sistemica. Valutazione dei possibili fattori di rischio in una ampia coorte di pazienti e ruolo degli autoanticorpi specifici della malattia.
LE ALTERAZIONI DEL MICROCIRCOLO NELLE MALATTIE RARE DI COMPETENZA REUMATOLOGICA: STUDIO CAPILLAROSCOPICO E RICERCA DELLE POSSIBILI CORRELAZIONI CON BIOMARCATORI CIRCOLANTI DI DANNO ENDOTELIALE
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma